These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9761121)

  • 21. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
    Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
    Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.
    Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R
    Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer.
    Higashiyama M; Taki T; Ieki Y; Adachi M; Huang CL; Koh T; Kodama K; Doi O; Miyake M
    Cancer Res; 1995 Dec; 55(24):6040-4. PubMed ID: 8521390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
    Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
    Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A; Lamb PW; Barrett JC
    Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.
    Imai Y; Sasaki T; Shinagawa Y; Akimoto K; Fujibayashi T
    Oral Oncol; 2002 Sep; 38(6):557-61. PubMed ID: 12167433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
    Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
    Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
    Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
    Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.
    Aryee DN; Ambros I; Ambros PF; Muehlbacher K; Luegmayr A; Yoshie O; Kovar H
    Pediatr Res; 2002 Aug; 52(2):279-85. PubMed ID: 12149507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung.
    Adachi M; Taki T; Huang C; Higashiyama M; Doi O; Tsuji T; Miyake M
    J Clin Oncol; 1998 Mar; 16(3):1060-7. PubMed ID: 9508191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression.
    Houle CD; Ding XY; Foley JF; Afshari CA; Barrett JC; Davis BJ
    Gynecol Oncol; 2002 Jul; 86(1):69-78. PubMed ID: 12079303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression.
    Woegerbauer M; Thurnher D; Houben R; Pammer J; Kloimstein P; Heiduschka G; Petzelbauer P; Erovic BM
    Mod Pathol; 2010 May; 23(5):751-62. PubMed ID: 20118909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases.
    Friess H; Guo XZ; Berberat P; Graber HU; Zimmermann A; Korc M; Büchler MW
    Int J Cancer; 1998 Aug; 79(4):349-55. PubMed ID: 9699525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
    Guo X; Friess H; Graber HU; Kashiwagi M; Zimmermann A; Korc M; Büchler MW
    Cancer Res; 1996 Nov; 56(21):4876-80. PubMed ID: 8895737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Adachi M; Huang CL; Taki T; Kasugai T; Ishiguro S; Nakamori S; Miyake M
    Int J Cancer; 1997 Apr; 74(2):205-11. PubMed ID: 9133457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer.
    Miyake M; Nakano K; Itoi SI; Koh T; Taki T
    Cancer Res; 1996 Mar; 56(6):1244-9. PubMed ID: 8640807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells.
    Mantegazza AR; Barrio MM; Moutel S; Bover L; Weck M; Brossart P; Teillaud JL; Mordoh J
    Blood; 2004 Aug; 104(4):1183-90. PubMed ID: 15130945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins.
    Rubinstein E; Le Naour F; Lagaudrière-Gesbert C; Billard M; Conjeaud H; Boucheix C
    Eur J Immunol; 1996 Nov; 26(11):2657-65. PubMed ID: 8921952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.